GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (FRA:7UM0) » Definitions » Other Stockholders Equity

Zelluna ASA (FRA:7UM0) Other Stockholders Equity : €5.54 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Other Stockholders Equity?

Zelluna ASA's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €5.54 Mil.

Zelluna ASA's quarterly Other Stockholders Equity declined from Jun. 2024 (€5.80 Mil) to Sep. 2024 (€5.57 Mil) and declined from Sep. 2024 (€5.57 Mil) to Dec. 2024 (€5.54 Mil).

Zelluna ASA's annual Other Stockholders Equity increased from Dec. 2022 (€3.99 Mil) to Dec. 2023 (€5.28 Mil) and increased from Dec. 2023 (€5.28 Mil) to Dec. 2024 (€5.54 Mil).


Zelluna ASA Other Stockholders Equity Historical Data

The historical data trend for Zelluna ASA's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA Other Stockholders Equity Chart

Zelluna ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.47 2.29 3.99 5.28 5.54

Zelluna ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.28 5.48 5.80 5.57 5.54

Zelluna ASA Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Zelluna ASA Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Zelluna ASA Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Zelluna ASA Headlines

No Headlines